DK0622372T3 - Hidtil ukendt forbindelse, Leustroducsin H, dens fremstilling og dens terapeutiske anvendelse - Google Patents

Hidtil ukendt forbindelse, Leustroducsin H, dens fremstilling og dens terapeutiske anvendelse

Info

Publication number
DK0622372T3
DK0622372T3 DK94302367T DK94302367T DK0622372T3 DK 0622372 T3 DK0622372 T3 DK 0622372T3 DK 94302367 T DK94302367 T DK 94302367T DK 94302367 T DK94302367 T DK 94302367T DK 0622372 T3 DK0622372 T3 DK 0622372T3
Authority
DK
Denmark
Prior art keywords
leustroducsin
preparation
therapeutic use
hitherto unknown
unknown compound
Prior art date
Application number
DK94302367T
Other languages
English (en)
Inventor
Yukio Sugimura
Tomoyuki Shibata
Kazuhiko Tamaki
Shinwa Kurihara
Takafumi Kohama
Akio Shiraishi
Tomowo Kobayashi
Kazuhiko Sasagawa
Naomi Shimazaki
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Application granted granted Critical
Publication of DK0622372T3 publication Critical patent/DK0622372T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6552—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK94302367T 1993-04-23 1994-03-31 Hidtil ukendt forbindelse, Leustroducsin H, dens fremstilling og dens terapeutiske anvendelse DK0622372T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9805893 1993-04-23

Publications (1)

Publication Number Publication Date
DK0622372T3 true DK0622372T3 (da) 1999-02-15

Family

ID=14209715

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94302367T DK0622372T3 (da) 1993-04-23 1994-03-31 Hidtil ukendt forbindelse, Leustroducsin H, dens fremstilling og dens terapeutiske anvendelse

Country Status (18)

Country Link
US (1) US5409912A (da)
EP (1) EP0622372B1 (da)
JP (1) JPH072886A (da)
CN (1) CN1050845C (da)
AT (1) ATE166058T1 (da)
AU (1) AU665488B2 (da)
CA (1) CA2121735A1 (da)
CZ (1) CZ286364B6 (da)
DE (1) DE69410159T2 (da)
DK (1) DK0622372T3 (da)
ES (1) ES2116528T3 (da)
FI (1) FI941850L (da)
HU (1) HU220223B (da)
IL (1) IL109227A (da)
NO (1) NO303640B1 (da)
NZ (1) NZ260364A (da)
PH (1) PH30180A (da)
RU (1) RU2098422C1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6040335A (en) * 1995-10-17 2000-03-21 Suntory Limited Therapeutics for thrombocytopenia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2865302B2 (ja) * 1988-02-13 1999-03-08 サントリー株式会社 ２―ピラノン誘導体及びその製造法並びにそれを含む抗菌剤
AU649116B2 (en) * 1991-03-27 1994-05-12 Sankyo Company Limited New compounds, named the "Leustroducins", their preparation and their therapeutic uses
JPH05213758A (ja) * 1992-02-06 1993-08-24 Sankyo Co Ltd 血小板増多剤

Also Published As

Publication number Publication date
FI941850A7 (fi) 1994-10-24
DE69410159T2 (de) 1999-01-28
PH30180A (en) 1997-01-21
EP0622372B1 (en) 1998-05-13
US5409912A (en) 1995-04-25
AU5932394A (en) 1994-10-27
JPH072886A (ja) 1995-01-06
CZ96494A3 (en) 1994-11-16
CN1050845C (zh) 2000-03-29
ATE166058T1 (de) 1998-05-15
HK1007857A1 (en) 1999-04-23
HUT68015A (en) 1995-05-29
IL109227A (en) 1998-01-04
NO303640B1 (no) 1998-08-10
FI941850A0 (fi) 1994-04-21
IL109227A0 (en) 1994-07-31
CN1105027A (zh) 1995-07-12
NO941478D0 (no) 1994-04-22
RU2098422C1 (ru) 1997-12-10
ES2116528T3 (es) 1998-07-16
AU665488B2 (en) 1996-01-04
HU220223B (hu) 2001-11-28
FI941850L (fi) 1994-10-24
HU9401159D0 (en) 1994-07-28
DE69410159D1 (de) 1998-06-18
NO941478L (no) 1994-10-24
NZ260364A (en) 1995-07-26
CZ286364B6 (cs) 2000-03-15
CA2121735A1 (en) 1994-10-24
EP0622372A1 (en) 1994-11-02

Similar Documents

Publication Publication Date Title
FI905983A0 (fi) Aminosyraderivat.
FI935675A0 (fi) Pyrazolopyrimidiner
NO2011018I1 (no) Eribulin og farmasøytisk akseptable salter derav
ATE248837T1 (de) Chinuclidin-acrylamide
NO921654L (no) Benzoisothiazol- og bezoisoksazol-3-karboksamider, en fremgangsmaate for fremstilling av disse og deres bruk som medikamenter
DK0565549T3 (da) Anvendelse af 1,3-oxathiolannucleosidanaloger til fremstilling af et præparat til behandling af hepatitis B
DK132188A (da) Anvendelse af tetrahydrobenz(c,d)indol-6-carboxamider som anxiolytika
MD1560F2 (en) Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses.
FI923664A0 (fi) Piperidinderivat.
SE8102220L (sv) Anvendning av substituerade derivat av 4-fenyl-4-oxo-2-butensyra sasom lekemedel
ES2054011T3 (es) Un proceso para la preparacion de un compuesto, "leualacina".
DK0617959T3 (da) Lægemiddel til behandling af hudsygdomme
DK0622372T3 (da) Hidtil ukendt forbindelse, Leustroducsin H, dens fremstilling og dens terapeutiske anvendelse
DE69627519D1 (de) Sesquiterpen-derivate mit antiviraler aktivität
MX9205408A (es) Metodo para tratar hipertension.